In NCT’s Clinical and Translational Cancer Programs, DKFZ and HUMS groups collectively address precision oncology.
NCT Clinical and Translational Research Groups
Cancer programs in Clinical Discovery, Molecular Diagnostics, Immunotherapy, Radiation Oncology and Cancer Prevention, and Early Detection & Outcomes align with DKFZ basic cancer research topics. The translational oncology-related groups on the Neuenheim Medical Campus include more than 85 investigators driving numerous peer-reviewed research projects, totaling more than €125 million in grant funding in 2010–2012. Major program project grants, including one excellence cluster, the German Translational Cancer Research Consortium (DKTK), the Helmholtz Initiative on Personalized Medicine (iMed), six SFBs, two Helmholtz Alliances, eight Cancer Aid PPGs, and 46 multicenter BMBF Projects, tackle areas of high relevance in oncology and related sciences.